The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study - 6 month results.

Arshad M KhananiAamir A AzizHannah KhanAshwin GuptaOhidul MojumderAigerim SaulebayevaAshkan M AbbeyDavid R P AlmeidaRobert L AveryHimanshu K BandaMark R BarakatRamanath BhandariEmmanuel Y ChangSara J HaugNikolas J S LondonLuke MeinVeeral S ShethJeremy D WolfeMichael A SingerCarl J Danzig

Published in: Eye (London, England) (2023)

Faricimab has demonstrated improvement or maintenance of visual acuity for patients with nAMD, along with rapid improvement of anatomical parameters. It has been well-tolerated with low incidence of treatable intraocular inflammation. Future data will continue to investigate faricimab for real-world patients with nAMD.

Keyphrases

age related macular degeneration
electronic health record
current status
big data
machine learning
data analysis
cataract surgery
endothelial cells
loop mediated isothermal amplification